This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Diagnosis of Melanoma
and you are
between 18 and 80
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Some Akt inhibitors have produced functional cardiovascular effects such as marked hypotension that may limit their clinical benefit. There are no current data on whether this autonomic failure presents in humans at clinically used doses. We will test the hypothesis that Akt inhibition causes an acute decrease in sympathetic tone and lowers blood pressure.

Provided treatments

  • Behavioral: Autonomic Function Tests
  • Other: supine and standing catecholamines

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01593579. The sponsor of the trial is Vanderbilt University and it is looking for 0 volunteers for the current phase.
Official trial title:
Autonomic Phenotype Before and After Akt Inhibition: Akt Therapy for Melanoma Sub-study